The HSP70 Molecular Chaperone Is Not Beneficial in a Mouse Model of α-synucleinopathy

Open Access

Peer-reviewed

Research Article

Derya R. Shimshek ,

* E-mail: derya.shimshek@novartis.com

Affiliation Neuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
⨯
Matthias Mueller,

Affiliation Developmental and Molecular Pathways/Model Disease Centre, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
⨯
Christoph Wiessner,

Affiliation Neuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
⨯
Tatjana Schweizer,

Affiliation Neuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
⨯
P. Herman van der Putten

Affiliation Neuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland
⨯

Reader Comments (3)

Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Genetically modified animals
Is the Subject Area "Genetically modified animals" applicable to this article?

Thanks for your feedback.
Brainstem
Is the Subject Area "Brainstem" applicable to this article?

Thanks for your feedback.
Spinal cord
Is the Subject Area "Spinal cord" applicable to this article?

Thanks for your feedback.
Immunoblotting
Is the Subject Area "Immunoblotting" applicable to this article?

Thanks for your feedback.
Monomers
Is the Subject Area "Monomers" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Animal behavior
Is the Subject Area "Animal behavior" applicable to this article?

Thanks for your feedback.